ANI Pharmaceuticals's total assets for Q4 2024 were $1.28B, a decrease of -0.29% from the previous quarter. ANIP total liabilities were $855.17M for the fiscal quarter, a -0.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.